Finally, in a multitumor study, serum IL-8 levels correlated positively with tumor burden and negatively with OS and ORR in patients with various solid cancers, including MM patients (n = 24) treated with BRAFi and ipilimumab [111]. The gene discussed is CXCL8; the disease is neoplasm.